MagnetOs Granules

Move the needle in fusion with our foundational, proven solution

Strong foundation & proven - MagnetOs Granules is the basis for all MagnetOs formulations and has been 510(k)-cleared since 2017. This foundational technology is supported by an unprecedented blend of scientific, preclinical, and clinical studies through our global research program, Project Fusion.
Harnessing the immune system - MagnetOs is capable of polarizing macrophages from the M1 pro-inflammatory to the M2 pro-healing phenotype, which is known to influence bone growth through secretion of proteins such as BMP-2. MagnetOs has been shown in pre-clinical studies to form bone even in soft tissue without added cells or growth factors. These features combine to make MagnetOs an active player in providing predictable fusions.
Equivalent to autograft - In fact, MagnetOs Granules as a standalone bone graft reached higher fusion rates than the gold standard of autograft. This is based on results of an observer blinded, randomized, controlled, intrapatient, multi-center clinical trial of instrumented posterolateral fusions, as assessed by fine-cut CT scans at one year follow-up. The MagnetOs Granules technology is also proven to be equivalent to autograft for spinal fusions in multiple pre-clinical models.